12.8 C
Wednesday, March 29, 2023
- Advertisement -


Approval to phase II/III clinical trials

DCGI Approves Phase II/III Clinical Trial Of Covaxin In The Age Group Of 2 To 18 Years

The DCGI has accorded permission to conduct the Phase II-III clinical trial of Covaxin in the age group of two to 18-years-old to the Hyderabad based manufacturer Bharat Biotech International Ltd (BBIL). The trials will be conducted in 525 health volunteers

Latest news

- Advertisement -